NDA[removed]NDA[removed]Page 6 Baraclude™

First Page		Document Content
Date: 2009-03-31 15:18:19 Medicine Entecavir Lamivudine Hepatitis B Reverse-transcriptase inhibitor Viral hepatitis Nucleoside analogue Adefovir Antiretroviral drug Purines Chemistry Organic chemistry		NDA[removed]NDA[removed]Page 6 Baraclude™ Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 628,06 KB Share Document on Facebook

	FOR PEOPLE WITH HIV AND/OR VIRAL HEPATITIS AND THOSE SEEKING PrEP How to choose a health plan in Covered California: Do it before January 31, 2017! CONTRIBUTORS: Project Inform, APLA Health, San Francisco AIDS Foundat DocID: 1t9aO - View Document
	www.honoreform.org Hepatitis Outbreaks’ National Organization for Reform HONOReform is the only national advocacy organization Based in Nebraska and active on Capitol Hill and DocID: 1rtXF - View Document
	WHAT WE NEED TO KNOW ABOUT VACCINATION AND TITRE TESTING Professor Michael J. Day BSc BVMS(Hons) PhD DSc DiplECVP FASM FRCPath FRCVS School of Veterinary Sciences, University of Bristol INTRODUCTION DocID: 1rgb0 - View Document
	Microsoft Word - Viral Hep Conference-updated (2) DocID: 1r8F5 - View Document
	Fresh Concentrate 118 White Paper New GNx2 Technology Cleaning System is Granted EPA Registration as a Sanitizer/Virucide (EPA Registration NoGNx2 is a newly developed cleaning system that is a hydrogen perox DocID: 1r5YW - View Document